CEPiA manufactures and supplies a variety of biotech and chemical intermediates, as well as APIs. Customers in pharmaceutical industry can have access to almost 200 high-quality APIs, manufactured in our 16 chemical and biotech sites.
- Traditional chemistry to biotechnology
- Small-scale to large-scale production
- Various grades of APIs (sieving, milling, micronisation)
- Knowledge and expertise sharing from Sanofi network
- Sustainable development and ethical chart
- Sanofi sites are regularly inspected by international health authorities with success
- Regulatory and quality standards
- Regulatory and quality support with dedicated team
- Vitamin B12 and derivatives
- Antibiotics and antituberculosis
- Packaging customisation
- Customised product grade
- Analgesics and nonsteroidal anti-inflammatory drugs (NSAIDs)
- CNS for oral and injectable applications
- Human recombinant insulin for cells culture (tamsulosine)
- Anaesthetics (articaine)
- Systemic and cardiovascular
- Metabolic disorders and anti-allergics
- Non-fluorinated glucocorticoids and derivatives (hydrocortisone, prednisone)
- Fluorinated glucocorticoids and derivatives (dexamethasone, triamcinolone)
- Minearlocorticoids (spironolactone, canrenone)
- World number one
- Development of pulmonary arterial hypertension (PAH) portfolio (epoprostenol, Iloprost)
- Development of ophthalmology portfolio (latanoprost, travoprost)
- Around 17 prostagladin APIs on catalogue
- Process development and scale-up of new chemical entities
- Leading codeine producer and exporter
- From poppy seeds to APIs
- 30 narcotics and antagonists in portfolio
- Morphine derivatives
- Thebaine derivatives
- Synthtic opioids
- 80 years of experience in alkaloid extraction
Click here for more information.